Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	90679
Country	China

Received	2023-12-19 09:14
Peer-Review Started	2023-12-19 09:14
To Make the First Decision
Return for Revision	2024-01-15 02:01
Revised	2024-01-25 00:54
Second Decision	2024-02-07 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-02-07 03:01
Articles in Press	2024-02-07 03:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-13 06:54
Publish the Manuscript Online	2024-03-22 11:13

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Xiao-Yan Liu, Hong-Nian Pan and Yue Yu
ORCID	Author(s) ORCID Number Xiao-Yan Liu http://orcid.org/0009-0005-9226-5384 Hong-Nian Pan http://orcid.org/0009-0008-2004-0209 Yue Yu http://orcid.org/0000-0002-3617-2037
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 31870993 Fundamental Research Funds for the Central Universities WK9110000005 Anhui Provincial Health Research Project AHWJ2022c020 Anhui Medical University Campus level Research Fund 2020xkj229 Lu'an City Science and Technology Plan Project 2022lakj009 New Technology and Project of Lu'an People's Hospital 2021xjs10
Corresponding Author	Yue Yu, MD, PhD, Chief Physician, Professor, Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 9 Lujiang Road, Hefei 230001, Anhui Province, China. yuyuemd@ustc.edu.cn
Key Words	Erlotinib; Chemotherapy; Advanced pancreatic cancer; Efficacy; Safety; Meta-analysis
Core Tip	There is currently no consensus in the literature regarding which treatment (erlotinib combined with chemotherapy vs chemotherapy alone) is more beneficial among patients with pancreatic cancer. To the best of our knowledge, this is the first systematic review and meta-analysis to compare erlotinib and chemotherapy. We investigated the overall survival, disease control rate, progression-free survival, and safety of the two treatments.
Publish Date	2024-03-22 11:13
Citation	Liu XY, Pan HN, Yu Y. Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis. World J Gastrointest Surg 2024; 16(3): 921-931
URL	https://www.wjgnet.com/1948-9366/full/v16/i3/921.htm
DOI	https://dx.doi.org/10.4240/wjgs.v16.i3.921

Full Article (PDF)	WJGS-16-921-with-cover.pdf
PRISMA 2009 Checklist	90679-PRISMA 2009 Checklist.pdf
Manuscript File	90679_Auto_Edited-JLW.docx
Answering Reviewers	90679-Answering reviewers.pdf
Audio Core Tip	90679-Audio core tip.mp3
Biostatistics Review Certificate	90679-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	90679-Conflict-of-interest statement.pdf
Copyright License Agreement	90679-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	90679-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	90679-Language certificate.pdf
Peer-review Report	90679-Peer-review(s).pdf
Scientific Misconduct Check	90679-CrossCheck.png
Scientific Misconduct Check	90679-Bing-Wang JL-2.png
Scientific Editor Work List	90679-Scientific editor work list.pdf
CrossCheck Report	90679-CrossCheck report.pdf